ライフサイエンスコーパス: urine test

1 5 and September 2018, 78.0% had >=1 positive urine test.

2 erences in rates of submission of a positive urine test.

3 by a history of amenorrhea and confirmed by urine test.

4 etection of renal cancer using a noninvasive urine test.

5 f-reported medication logs and for a subset, urine tests.

6 Pregnancy was assessed with monthly urine tests.

7 immunoassay for serum free-light-chains with urine tests.

8 5%) had NB detected by PET but not by BM and urine tests.

9 entified through readily available blood and urine tests.

10 sitive urine with 3 samples positive by both urine tests.

11 ed in interventions aimed at reducing excess urine testing.

12 testing in saliva and cCMV was confirmed by urine testing.

13 d evaluated the performance of the Phase HPV Urine Test, a qualitative real-time PCR assay for the de

14 antial burden on patient quality of life and urine testing accounts for the majority of workload in m

15 the process for the most part simple, though urine testing and height self-assessment presented some

16 GF ratio was found to be 4.0 times higher in urine tests and 1.5 times higher in tests utilizing urin

17 % (23 positive test results out of 393 total urine tests and a total of 3986 clinic visits) vs 7.6% i

18 c blood pressure, and 10 commonly used blood/urine tests and dietary intake values to identify young,

19 on Rate (ESR), haemoglobin-A1C (HbA1c), spot urine tests and the SII.

20 was defined as any opioid-positive or missed urine test, and relapse as two or more consecutive lapse

21 use during pregnancy by maternal hair test, urine test, and self-report in a sample of 691 patients

22 ood and respiratory sample culture, BinaxNOW urine testing, and UAD.

23 on emission tomography, as well as blood and urine tests, are used to identify brain tumors.

24 preliminary support for the proposal to use urine testing as a primary or secondary screening tool f

25 .73 mm; 95% CI: -5.91, 2.44) than a positive urine test at delivery (-182 g (95% CI: -295, -69.8) and

26 lification technologies may make noninvasive urine testing available for young men and for young wome

27 antenatal care (blood pressure measurement, urine tests, blood tests, and information on complicatio

28 The Phase HPV Urine Test combines a proprietary urine collection devic

29 indicating minimal or no opioid use based on urine test-confirmed self-reports.

30 Urine testing could prevent patients from being undiagno

31 to Jan 18, 2022 we enrolled 49 women in the urine-test counselling group and 51 in the standard of c

32 urine tenofovir was detectable in 65% in the urine-test counselling group and 71% in the standard of

33 Nine (21%) of 42 in the urine-test counselling group had hair samples at 12 mont

34 sus counselling informed by the urine assay (urine-test counselling group) every 3 months for 12 mont

35 in the standard of care group compared with urine-test counselling were 3.53 (95% CI 1.03-12.03; p=0

36 d Health Organization-endorsed point-of-care urine test designed to detect active TB disease in human

37 Three urine tests detected cocaine but found no presence of am

38 2-4.5) more likely to submit an EtG-negative urine test during the 12-week intervention period, attai

39 0)more likely to submit a stimulant-negative urine test during treatment.

40 ined the national prevalence and patterns of urine testing during adult inpatient admission in the Un

41 ents with any cardiac disease, drug-positive urine test, electrolyte abnormalities, and changes in th

42 An accurate urine test for diverse populations with active tuberculo

43 INH acetylator genotypes were determined and urine tested for INH metabolites to confirm adherence.

44 rd screening for substances of abuse and had urine tested for the presence of levamisole by liquid ch

45 Self-reported days of illicit opioid use, urine testing for illicit opioids, human immunodeficienc

46 However, urine testing for methamphetamine does not identify pati

47 During these years, the survey included urine testing for trichomoniasis using transcription-med

48 Urine tests for Chlamydia organisms should not be used a

49 Urine tests for Chlamydia trachomatis permit expansion o

50 m erythropoietin (EPO) levels, and stool and urine tests for occult blood.

51 are medication fills, outpatient visits, and urine tests for opioid use disorder in January-May 2020

52 rum assays could replace Bence Jones protein urine tests for patients with light-chain multiple myelo

53 Active marijuana users, with positive urine tests for THC, showed greater activation in the fr

54 nd had biological samples (serum, plasma, or urine) tested for confirmation with PCR at the National

55 high-sensitivity detection via a noninvasive urine test has become the goal for urothelial carcinoma

56 methods of CKD and its complications through urine testing in the future.

57 Broger and Nicol et al. investigated 3 rapid urine tests in 372 ambulatory HIV-negative individuals s

58 ceptor, on the prevalence of opioid-positive urine tests in African-Americans (n=77) or European-Amer

59 an fail to detect some bladder cancers, so a urine test is frequently part of the evaluation.

60 Overuse of urine testing is a driver of inappropriate antimicrobial

61 The sex bias in urine testing is not clinically supported and must be ad

62 n relapse (three consecutive opioid-positive urine tests), maximum consecutive days of heroin abstine

63 An array of self-report and urine testing measures were examined secondarily to asse

64 PMCA; moreover, they suggest that the PrP(D) urine test might allow for the diagnosis and identificat

65 ves were contingent on monthly point-of-care urine tests negative for ethyl glucuronide (groups 2 and

66 ination of 3 measures (OMT, self-report, and urine test), none of which were perfect.

67 Study visits with urine testing occurred weekly for 12 weeks, then 6 times

68 ecimens) and routine-screening (confirmatory urine testing of positive saliva results) implementation

69 Compulsory urine testing of prisoners for drugs, a control initiati

70 Toxicity was measured using blood and urine tests of renal, hepatic, thyroid, and bone marrow

71 atients in the routine care group missed the urine test on day 3, 4, or 5.

72 mary care populations; 14 studies of protein urine test performance among women being evaluated for s

73 The Phase HPV Urine Test provides accurate, reproducible, and non-inva

74 rdance between Determine-LAM and SILVAMP-LAM urine tests requires further investigation.

75 Alcohol-negative ethyl glucuronide (EtG) urine test result (defined as EtG<150 ng/mL).

76 rs (>/=4 of 6 months without opioid-positive urine test result [monthly and 4 times randomly] and sel

77 Opioid-positive urine test result at weeks 4, 8, and 12.

78 n should be discontinued after an unexpected urine test result can be clinically complex.

79 or more urine samples and 1 alcohol-positive urine test result during the observation period before r

80 needed to treat to achieve a negative weekly urine test result was 3.1.

81 bsample of 2,643 (48.2%) participants with a urine test result, 34.7% of those living with HIV were u

82 up had higher proportions of opioid-positive urine test results at weeks 4 and 8 but not at week 12 (

83 ine group had fewer methamphetamine-positive urine test results compared with participants assigned t

84 use of these supplements can cause positive urine test results for metabolites of the prohibited ste

85 19-norandrostenedione is sufficient to cause urine test results positive for 19-norandrosterone, the

86 ople with one or more confirmatory sputum or urine test results that were positive, the proportion de

87 significantly higher percentage of scheduled urine test results were opiate negative (64% vs 32%; P =

88 e effective than STAR in percentage of clean urine test results, survival in treatment, and attendanc

89 me was reduction in methamphetamine-positive urine test results.

90 rs received matching vouchers independent of urine test results.

91 There was no association with urine testing (RR, 0.95; 95% CI, 0.77-1.17; low certaint

92 e haemoglobin, triage test combinations, and urine tests showed comparatively worse results.

93 he ICER would be less than $1100 per DALY if urine test specificity is 0.87 or greater and costs $2 p

94 onal status, lower haemoglobin, and positive urine tests (TB-LAM and/or Xpert MTB/RIF) were associate

95 ional status, lower hemoglobin, and positive urine tests (TB-LAM and/or Xpert MTB/RIF) were associate

96 ype were less likely to have opioid-positive urine tests than those in the combined CT and TT genotyp

97 In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM

98 The observed correlations among spot urine tests, the SII and OCTA parameters support the rol

99 Primary outcomes, assessed by urine testing three times per week, were days to first h

100 d suggest feasibility of an in vivo human CF urine test to validate drug efficacy.

101 of ATTR-CM only when combined with blood and urine testing to exclude a monoclonal protein.

102 ensor platform can be integrated with simple urine tests to offer cost-effective detection of various

103 state (IntelliScore) "EPI" is a non-invasive urine test utilizing RNA from exosomes to provide a risk

104 cted stool and blood; the lactulose-mannitol urine test was also conducted at all visits except at 1

105 Urine testing was common and frequently repeated during

106 e of cocaine abstinence during thrice-weekly urine testing was conducted.

107 nsitive than previously reported, but serial urine testing was useful in monitoring disease resolutio

108 ts, blood pressure monitoring, and blood and urine testing) was positively associated with health-see

109 asive bacterial infection based on blood and urine testing were included.

110 group (34.6%), and rates of opioid-negative urine tests were 72 of 130 tests in the XRB group (55.3%

111 X-rays, ultrasounds, and urine tests were most commonly performed in children wit

112 ward for observation, and routine blood and urine tests were performed.

113 e concentration in hair (which was higher if urine tests were positive) had a dose-response relations